D'Or Institute for Research and Education Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04480593
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

D'Or Institute for Research and Education